Adimmune Market Cap

Adimmune has a market cap or net worth of 7.40 billion as of March 9, 2026. Its market cap has decreased by -27.33% in one year.

Market Cap

7.40B

Enterprise Value

9.01B

Revenue

1.20B

Ranking

n/a

PE Ratio

n/a

Stock Price

17.55

Market Cap Chart

Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 7.40B, a decrease of -33.34%. That is a compound annual growth rate of -2.59%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	7.40B	-7.39%
Dec 31, 2025	7.99B	-5.72%
Dec 31, 2024	8.47B	-39.37%
Dec 29, 2023	13.97B	-7.97%
Dec 30, 2022	15.18B	-20.83%
Dec 30, 2021	19.18B	-20.41%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Acepodia	7.48B
TaiGen Biopharmaceuticals Holdings	8.68B
Mycenax Biotech	6.77B
PharmaEngine	8.78B
Savior Lifetec	6.29B
Gongwin Biopharm Holdings	9.81B
Sinphar Pharmaceutical	5.86B
Steminent Biotherapeutics	5.42B

Market Cap Rankings